Skip to Main Content

Advertisement

Skip Nav Destination

Tumor Biology

Studies that investigate the intercellular interactions and physiology governing tumor development and progression

Latest in Tumor Biology
Akira Saito, Joji Kitayama et al.
Dipeptidyl peptidase IV inhibitor (DPP-4i) has been shown to act either as a promoter or as a suppressor for cancer. Although epidemiologic studies suggest that DPP-4i does not correlate with the development of malignancies, its effects on cancer metastases are controversial. We evaluated the impact of DPP-4i on ...
Mehrdad Zarei, Rupesh Shrestha et al.
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis and chemotherapy with gemcitabine has limited effects and is associated with development of drug resistance. Treatment of Panc1 and MiaPaca2 pancreatic cancer cells with gemcitabine induced expression of the orphan nuclear receptor ...
Joshua L.D. Parris, Thibaut Barnoud et al.
NRAS-mutant melanoma is currently a challenge to treat. This is due to an absence of inhibitors directed against mutant NRAS, along with adaptive and acquired resistance of this tumor type to inhibitors in the MAPK pathway. Inhibitors to MEK have shown some promise for NRAS-mutant melanoma. In this work, we explored the ...
Close Modal

or Create an Account

Close Modal
Close Modal